news & events
portfolio news
18.09.18
BioClin Therapeutics Announces New Leadership to Advance Late-Stage Bladder Cancer Development Program
05.09.18
Minoryx Therapeutics announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)
04.09.18
Aura Biosciences Boosts Finance Team with Two Key Appointments, Preparing to Move Into Late-Stage Clinical Development in Ocular Melanoma
06.08.18
Sanifit announces completion of enrollment in CaLIPSO – its Phase 2b Study for the Treatment of Cardiovascular Calcification in End-Stage-Renal-Disease Patients on Haemodialsis
25.07.18
Aura Biosciences Presents Interim Phase 1b/2 Data at the American Society of Retina Specialists (ASRS) Annual Meeting
10.07.18
CorWave’s next-generation LVAD, Neptune, receives funding
27.06.18
Leading Prenatal App BabyscriptsTM Announces Acquisition of iBirthTM
27.06.18
BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
17.06.18
Aura Biosciences Announces Update of Clinical Safety and Efficacy Data on Lead Candidate AU-011 for Choroidal Melanoma
12.06.18
Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board
